University Of Brescia

The clinical research here focuses on mental disorders, with studies centered on major depressive disorder and bipolar depression. These trials aim to assess whether an early, more intensive treatment approach can improve symptom relief compared with standard care in people who have not responded well to first-line therapy.

• Evaluating treatment effectiveness in major depressive disorder
• Studying response in bipolar depression
• Comparing intensified therapy with usual care

At this site in Brescia, the work is designed to better understand how to improve outcomes for patients with difficult-to-treat mood disorders.

Another key area of research involves schizophrenia and related conditions such as schizoaffective disorder and schizophreniform disorder. The trials are assessing whether intensified pharmacological treatment can reduce symptom severity more effectively than standard treatment, with a strong focus on clinical response in patients who have experienced early treatment failure.

• Testing treatment effectiveness in schizophrenia
• Including schizoaffective disorder and schizophreniform disorder
• Measuring improvement in psychotic symptoms

This research supports better care strategies for people living with complex psychotic illnesses, while helping clinicians compare new treatment approaches with routine practice.

The site’s overall trial portfolio is small but focused, with studies in psychiatry aimed at improving how symptom severity is managed across depressive and psychotic disorders. The main purpose is to generate clearer evidence on whether early treatment intensification can lead to better outcomes than treatment as usual.

• Improving care for mental disorders
• Assessing symptom change over time
• Supporting evidence-based treatment decisions

As an educational institution, the University Of Brescia contributes to clinically relevant research that may help shape future approaches to psychiatric care.